Company Overview:Penumbra, Inc. (NYSE: PEN) is recognized as a leader in the thrombectomy sector, committed to developing innovative medical technologies targeting complex conditions such as ischemic stroke.
Recent Developments:In the first quarter of 2025, Penumbra showcased significant growth, ...